To elucidate whether USP39 regulate β-catenin expression, cell proliferation, cell cycle, and tumor growth in HCC cells, knockdown and overexpression of USP39, β-catenin inhibitor ICG-001 were performed in HCC cell lines (SK-hep-1 and PLC/PRF/5). Here, USP39 is linked to hepatocellular carcinoma.